Work

Phase I study of nab-paclitaxel, gemcitabine, and bevacizumab in advanced cancers.

Year: 2017

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2017.35.15_suppl.2526

Authors: Shiraj Sen, Sarina Anne Piha-Paul, Shumei Kato, Daniel D. Karp, Filip Janku, Siqing Fu, Aung Naing, Shubham Pant, Apostolia Maria Tsimberidou, Vivek Subbiah, Razelle Kurzrock, Funda Meric-Bernstam, David S. Hong

Institutions: The University of Texas MD Anderson Cancer Center, University of California San Diego, University of Oklahoma Health Sciences Center, Moores Cancer Center

Language: English

Topic: Cancer Treatment and Pharmacology

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2735977258

Cites:

Cited by:

Related to: 10